Diabetes Clinical Trials

Showing 661-680 of 3,811 trials

Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.

NCT05368402

Primary objective \- To determine whether oral ladarixin versus placebo adjunctive therapy improves glycemic control in overweight, insulin resistant (IR) adult subjects with type 1 diabetes (T1D). Secondary objectives * To ascertain the effect of ladarixin on glycemic variability as per CGM derived parameters. * To determine the safety of oral ladarixin versus placebo adjunctive therapy in overweight, IR adult subjects with T1D.

Type 1 Diabetes

Dompé Farmaceutici S.p.A3 participantsStarted Sep 2022

Frosinone, Italy • Rome, Italy

COMPLETEDNA

Targeting Hyaluronan Accumulation Through Exercise in T2DM

NCT04383314

A pilot longitudinal study to examine hyaluronan (HA) accumulation in muscles of individuals with Type 2 diabetes mellitus (T2DM), and the effects of exercise on HA accumulation, muscle stiffness, strength, ankle joint mobility, and physical function. HA accumulation will be assessed non- invasively using magnetic resonance imaging.

Type 2 Diabetes Mellitus

NYU Langone Health30 participantsStarted Sep 2021

New York, New York, United States

Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.

Targeting Hyaluronan Accumulation Through Exercise in T2DM

Related Searches

AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy

Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.

Clinical Evaluation of Non-invasive Blood Glucose Meter

Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)

Observational Study to Evaluate the Efficacy and Safety of Teneligliptin

Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities

Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

Heat Shock Therapy to Improve Mitochondrial Function in Neuropathy

The Effect of Hypoxia on Type 2 Diabetes and Weight Loss

SPARK- a Digital Platform to Improve Self-management of Gestational Diabetes

Laughter Yoga on Blood Glucose Levels, Disease Perception and Perceived Stress Level

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

High-Protein Diets and Diabetes

A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM

The ELG Analysis of Glucose a Correlational to Blood Glucose Assay

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System